Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines

Ítems similars

• Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation
  per: Velloso, Fernando J., et al.
  Publicat: (2019)
• NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
  per: Velloso, Fernando J., et al.
  Publicat: (2019)
• Differential β(2)-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines
  per: Gargiulo, Lucía, et al.
  Publicat: (2014)
• The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
  per: Velloso, Fernando J, et al.
  Publicat: (2017)
• Ubiquitin specific protease 21 upregulation in breast cancer promotes cell tumorigenic capability and is associated with the NOD-like receptor signaling pathway
  per: Peng, Liang, et al.
  Publicat: (2016)